Viewing Study NCT01748292


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-02-01 @ 5:37 PM
Study NCT ID: NCT01748292
Status: COMPLETED
Last Update Posted: 2019-06-04
First Post: 2012-12-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Sponsor: Charles C Wykoff, PhD, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age related View
None Macular View
None sub retinal fluid View
None Age related Macular degeneration View